We are live on ! Find out more
N

Natixis Portfolio holdings

AUM $28B
1-Year Est. Return 26.79%
 

Natixis is a global financial services business line of Groupe BPCE, offering a range of services including corporate and investment banking, asset management, insurance, and wealth management, with a focus on green and sustainable finance.

This Fund
S&P 500
This Quarter Est. Return
+6.62%
1 Year Est. Return
+26.79%
3 Year Est. Return
+97.72%
5 Year Est. Return
+108.83%
10 Year Est. Return
+452.99%
AUM
$30.6B
AUM Growth
+$3.05B
Cap. Flow
+$1.77B
Cap. Flow %
5.79%
Top 10 Hldgs %
31.38%
Holding
1,236
New
202
Increased
348
Reduced
462
Closed
184

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$407M
2
C icon
Citigroup
C
+$258M
3
BIDU icon
Baidu
BIDU
+$198M
4
HON icon
Honeywell
HON
+$193M
5
TTD icon
Trade Desk
TTD
+$169M

Sector Composition

Rank Sector Weight
1 Technology 19.41%
2 Consumer Discretionary 19%
3 Communication Services 8.93%
4 Financials 7.58%
5 Healthcare 7.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
POWW icon
1026
Outdoor Holding Co
POWW
$239M
$152K ﹤0.01%
+25,600
New +$165K
CBAY
1027
DELISTED
Cymabay Therapeutics
CBAY
$150K ﹤0.01%
32,951
-2,073
-6% -$11.2K
NTP
1028
DELISTED
Nam Tai Property Inc.
NTP
$148K ﹤0.01%
+12,000
New +$112K
MBI icon
1029
MBIA
MBI
$288M
$133K ﹤0.01%
+13,800
New +$107K
CVE icon
1030
Cenovus Energy
CVE
$54.6B
$110K ﹤0.01%
14,681
+2,239
+18% +$15.7K
CODX
1031
Co-Diagnostics
CODX
$7.74M
$105K ﹤0.01%
367
-56
-13% -$22.4K
NOK icon
1032
Nokia
NOK
$50.8B
$103K ﹤0.01%
26,120
-119,297
-82% -$498K
GEO icon
1033
The GEO Group
GEO
$4.13B
$100K ﹤0.01%
+12,900
New +$106K
KGC icon
1034
Kinross Gold
KGC
$28.5B
$94K ﹤0.01%
14,087
-900
-6% -$6.26K
EPZM
1035
DELISTED
Epizyme, Inc
EPZM
$91K ﹤0.01%
+10,400
New +$108K
SRNE
1036
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$88K ﹤0.01%
10,700
-301,100
-97% -$3.18M
OPTN
1037
DELISTED
OptiNose
OPTN
$74K ﹤0.01%
+1,333
New +$81.1K
AUTL
1038
Autolus Therapeutics
AUTL
$386M
$72K ﹤0.01%
+12,600
New +$93.3K
IDEX
1039
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$63K ﹤0.01%
+174
New +$75.7K
AUY
1040
DELISTED
Yamana Gold, Inc.
AUY
$61K ﹤0.01%
14,038
-2,111
-13% -$10.1K
TXMD icon
1041
TherapeuticsMD
TXMD
$23.8M
$60K ﹤0.01%
900
+180
+25% +$14.1K
VCNX
1042
DELISTED
Vaccinex, Inc. Common Stock
VCNX
$53K ﹤0.01%
+85
New +$54.6K
BTG icon
1043
B2Gold
BTG
$5.16B
$51K ﹤0.01%
11,761
-2,416
-17% -$11.8K
CRVS icon
1044
Corvus Pharmaceuticals
CRVS
$1.1B
$51K ﹤0.01%
+16,500
New +$59.6K
ACAD icon
1045
Acadia Pharmaceuticals
ACAD
$4.25B
-170,240
Closed -$9.1M
ADM icon
1046
Archer Daniels Midland
ADM
$41.4B
-14,224
Closed -$717K
AEE icon
1047
Ameren
AEE
$31.5B
-760,276
Closed -$59.3M
AEO icon
1048
American Eagle Outfitters
AEO
$2.85B
-1,269,630
Closed -$25.5M
AHT
1049
Ashford Hospitality Trust
AHT
$21M
-1,273
Closed -$303K
AIV
1050
Aimco
AIV
$380M
-3,379,013
Closed -$17.8M

Similar funds

Natixis's Q1 2021 Portfolio in Review

As of Q1 2021, Natixis held 1,236 positions worth $30.6B, up 11% from $27.5B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Natixis deployed $1.77B of net new capital in Q1 2021, opening 202 new positions and adding to 348 existing holdings. Its largest new stake was iShares Russell 2000 ETF: 1,000,000 shares worth $221M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Tesla, an estimated $407M trimmed.

  • Natixis's largest Q1 2021 buy was iShares Russell 2000 ETF: 1,000,000 shares worth $221M.
  • Natixis added most to Amazon in Q1 2021, an estimated $1.1B increase.
  • Natixis's biggest Q1 2021 reduction was Tesla, cutting an estimated $407M.
  • Natixis fully exited Tiffany & Co. in Q1 2021, selling an estimated $108M.
  • Natixis's ten largest holdings make up 31% of its $30.6B portfolio in Q1 2021.
  • Natixis opened 202 new positions and closed 184 in Q1 2021.
  • Natixis's portfolio value rose 11% quarter-over-quarter to $30.6B.

Based on Natixis's 13F filing for Q1 2021, filed 14 May 2021.